These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6998556)

  • 21. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
    Joss RA; Goldberg RS; Yates JW
    Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.
    Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA
    Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
    Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
    Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group.
    Cancer; 1982 Mar; 49(6):1116-22. PubMed ID: 7037156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D
    Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
    Cohen MH; Schoenfeld D; Wolter J
    Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.
    Hahn RG; Temkin NR; Savlov ED; Perlia C; Wampler GL; Horton J; Marsh J; Carbone PP
    Cancer Treat Rep; 1978 Jul; 62(7):1093-5. PubMed ID: 356971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
    Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
    N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas.
    Vaughn C; Chapman J; Chinn B; Ward D; Groshko G; Maniscalco B; Reznik S; Piper D
    Am J Clin Oncol; 1989 Feb; 12(1):49-52. PubMed ID: 2492142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
    Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
    Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
    Posey LE; Morgan LR
    Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I evaluation of semustine in a weekly schedule.
    Koller CA; Schwalm D; Liepman M; Natale RB; Wheeler RH
    Cancer Treat Rep; 1983 Jun; 67(6):579-81. PubMed ID: 6861164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adults.
    Yap BS; Benjamin RS; Burgess MA; Murphy WK; Sinkovics JG; Bodey GP
    Cancer; 1981 Jun; 47(12):2807-9. PubMed ID: 7260872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential and combination chemotherapy of advanced gastric cancer.
    Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
    Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.